Accuray Inc
NASDAQ:ARAY
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.41
3.08
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ARAY stock under the Base Case scenario is 2.843 USD. Compared to the current market price of 1.895 USD, Accuray Inc is Undervalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Accuray Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ARAY cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Accuray Inc
Balance Sheet Decomposition
Accuray Inc
Current Assets | 323.2m |
Cash & Short-Term Investments | 68.6m |
Receivables | 92m |
Other Current Assets | 162.7m |
Non-Current Assets | 145.4m |
Long-Term Investments | 9.8m |
PP&E | 58.5m |
Intangibles | 57.7m |
Other Non-Current Assets | 19.3m |
Current Liabilities | 195.3m |
Accounts Payable | 50m |
Accrued Liabilities | 51.9m |
Other Current Liabilities | 93.4m |
Non-Current Liabilities | 228.3m |
Long-Term Debt | 164.4m |
Other Non-Current Liabilities | 63.9m |
Earnings Waterfall
Accuray Inc
Revenue
|
446.6m
USD
|
Cost of Revenue
|
-303.6m
USD
|
Gross Profit
|
142.9m
USD
|
Operating Expenses
|
-142.4m
USD
|
Operating Income
|
504k
USD
|
Other Expenses
|
-16m
USD
|
Net Income
|
-15.5m
USD
|
Free Cash Flow Analysis
Accuray Inc
USD | |
Free Cash Flow | USD |
ARAY Profitability Score
Profitability Due Diligence
Accuray Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
Accuray Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
ARAY Solvency Score
Solvency Due Diligence
Accuray Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Score
Accuray Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ARAY Price Targets Summary
Accuray Inc
According to Wall Street analysts, the average 1-year price target for ARAY is 6.248 USD with a low forecast of 5.555 USD and a high forecast of 7.35 USD.
Shareholder Yield
Current shareholder yield for ARAY is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
ARAY Price
Accuray Inc
Average Annual Return | 1.32% |
Standard Deviation of Annual Returns | 45.82% |
Max Drawdown | -76% |
Market Capitalization | 188.1m USD |
Shares Outstanding | 99 244 200 |
Percentage of Shares Shorted | 5.55% |
Ownership
ARAY Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 995 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The firm's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.
Contact
IPO
Employees
Officers
The intrinsic value of one ARAY stock under the Base Case scenario is 2.843 USD.
Compared to the current market price of 1.895 USD, Accuray Inc is Undervalued by 33%.